Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nucleus RadioPharma
Davidson, North Carolina, United Statesnucleusrad.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Commercial
01
Overview
Nucleus RadioPharma does not have its own clinical results as it operates as a CDMO. It enables the development, manufacturing, and supply chain of targeted radiotherapies for partners in the oncology space.
- Therapeutic areas
- Oncology
- Modalities
- RadiopharmaceuticalRadioligand therapyMedical device (radiopharmaceutical-focused)
- Industry
- Contract Manufacturing Organization
02
Partnerships
Mayo Clinic (strategic investor/collaborator)AstraZeneca (investor/partner)GE HealthCare, Echo Global Logistics, Fox Chase Cancer Center, Granger Management, Mercy Health, University of Missouri (investors/partners)
Beyond the preview
Go deeper on Nucleus RadioPharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nucleus RadioPharma.